Supplementary appendix
PARP inhibitors: Synthetic lethality in the clinic | Science
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
ShopUi
Olaparib: Cos'è, A Cosa Serve, Quando si Assume
A Wikipedia edit-a-thon for women in cancer research
PharmaWiki - Olaparib
PARP inhibitor - Wikipedia
令癌莎- Wikiwand
Olaparib CAS 763113-22-0 Watson International Limited
![Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805122020856-ga1.jpg "Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect")
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression - ScienceDirect
令癌莎- Wikiwand
Olaparib - Wikipedia
Olaparib – Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
olaparib | New Drug Approvals
Olaparib - Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
HemOnc.org | A Hematology Oncology Wiki
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment - ScienceDirect
Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
HemOnc.org | A Hematology Oncology Wiki
Olaparib - Wikipedia, la enciclopedia libre
